Full history for every metric is available with a Kvantra account
Akumin Inc. (AKU)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 105 | 155 | 247 | 251 | 421 | 750 | 738 |
| Operating profit | $m | 42 | 10 | |||||
| Net profit | $m | -9 | 8 | 9 | -18 | -35 | -152 | -258 |
| EPS reported | $ | -1.69 | -3.00 | |||||
| Operating cashflow per share | $ | 0.73 | 0.73 | |||||
| Capex per share | $ | 0.50 | 0.50 | |||||
| FCF per share | $ | 0.23 | 0.23 | |||||
| Free cash flow | $m | 21 | 21 | |||||
| Net debt | $m | 1,420 | 1,283 | |||||
| Book value equity | $m | -48 | -115 | |||||
| Book value per share | $ | -0.54 | -1.27 | |||||
| Number of shares | m | 89.46 | 90.5 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -1.33 | -0.23 | |||||
| P/S LTM | x | 0.09 | 0.04 | |||||
| P/FCF LTM | x | 3.12 | 1.22 | |||||
| EV/EBITDA LTM | x | 10.61 | 6.53 | |||||
| EV/Sales LTM | x | 1.98 | 1.78 | |||||
| Earnings Yield LTM | % | -235.74% | -586.93% | |||||
| FCF Yield | % | 32.04% | 81.79% | |||||
| Quality | ||||||||
| ROE | % | 314.50% | -531.99% | |||||
| ROIC | % | 2.54% | 2.54% | |||||
| Operating margin | % | 5.56% | 5.56% | |||||
| Gross margin | % | 18.84% | 18.84% | |||||
| FCF/Sales | % | 2.75% | 2.75% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +78.03% | -0.91% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | +365.13% | |||||
| Operating Profit Growth | % | +218.64% | -60.24% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.01 | 0.01 | |||||
| Net Debt/EBITDA | x | 10.15 | 10.15 | |||||
| EBIT/Net interest | x | 0.35 | 0.35 | |||||
| Net debt/market cap | % | 2208.6% | 4885.2% | |||||
| Net debt/Equity | x | -29.46 | -11.19 | |||||
| Gross debt/equity | x | -30.70 | -13.17 | |||||
Company overview
Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States. Its operations are divided into two main divisions: Radiology and Oncology. Through a network of roughly 200 imaging centers, which it either owns or manages, Akumin delivers a wide array of medical imaging modalities. These include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and various other diagnostic or interventional radiology procedures. The company extends its outpatient radiology and oncology services and comprehensive solutions to approximately 1,000 hospitals and healthcare systems spanning 46 states. Established in 2015, Akumin Inc. maintains its corporate headquarters in Plantation, Florida.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Akumin Inc. (AKU)
Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States. Its operations are divided into two main divisions: Radiology and Oncology. Through a network of roughly 200 imaging centers, which it either owns or manages, Akumin delivers a wide array of medical imaging modalities. These include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and various other diagnostic or interventional radiology procedures. The company extends its outpatient radiology and oncology services and comprehensive solutions to approximately 1,000 hospitals and healthcare systems spanning 46 states. Established in 2015, Akumin Inc. maintains its corporate headquarters in Plantation, Florida.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free